Celiac Disease Treatment Market Size, Share & Trends Analysis Report By Treatment (Vitamins & Minerals, Gluten-free Diet), By Route of Administration, By Distribution Channel, By Region,- Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2024-2034

Celiac Disease Treatment Market Size and Trends

The celiac disease treatment market size was exhibited at USD 615.25 million in 2024 and is projected to hit around USD 1893.88 million by 2034, growing at a CAGR of 11.9% during the forecast period 2024 to 2034.

Celiac Disease Treatment Market Key Takeaways:

• Vitamins and minerals dominated the market and accounted for the largest revenue share of 50.2% in 2024.
• Gluten-free diets are projected to grow at a CAGR of 10.8% over the forecast period.
• The oral route of administration led the market and accounted for the largest revenue share of 62.7% in 2024.
• The parenteral route of administration is expected to grow at a CAGR of 10.4% over the forecast period.
• The hospitals dominated the market and held the largest revenue share of 51.0% in 2024.
• Research centers are expected to grow at a CAGR of 9.6% over the forecast period.
• North America celiac disease treatment market dominated the global market and accounted for the largest revenue share of 41.8% in 2024.

Report Scope of Celiac Disease Treatment Market

This growth is attributed to the increasing prevalence of diagnosed cases, which has heightened the demand for effective treatments and diagnostic methods. In addition, growing public awareness regarding celiac disease symptoms and the importance of early diagnosis has led to more individuals seeking medical attention. Furthermore, the expanding gluten-free food industry supports the market by providing diverse dietary options. Advances in diagnostic technologies and ongoing research into new treatment modalities further contribute to market growth by improving the detection and management of the disease.

Governments of many nations are implementing various initiatives to create awareness about celiac disease and uplift the accessibility to diagnostics and treatment for every individual. For instance, some countries have conducted screening programs specifically targeting high-risk populations. In addition, point-of-care testing (POCT) for celiac disease has gained acceptance in the past few years because of its quick diagnostic proficiencies. This allows for timely diagnosis and enables early treatment, avoiding further severe risks to the patient. Along with increased disease awareness, key companies invest in drugs and gluten-free products to enhance patients' health and overall outcomes. The benefits of gluten-free products have led to the adoption and utilization of gluten-free items.

Furthermore, the market for celiac disease treatment is anticipated to expand worldwide, fueled by the development of anti-inflammatory drugs and therapeutic vaccines, rising healthcare expenditure, and continuous medical research, which further contribute to market growth. Adopting therapeutic products and rising diabetes cases in several countries is expected to surge market growth. In addition, R&D activities and expenditure for innovative treatment alternatives and practices executed by various healthcare organizations have opened more opportunities for market expansion of celiac disease treatment.

Celiac Disease Treatment Market By Treatment Insights

Vitamins and minerals dominated the market and accounted for the largest revenue share of 50.2% in 2024. This growth is driven by individuals with celiac disease, who often experience nutrient deficiencies due to the malabsorption of essential vitamins and minerals caused by intestinal damage. Supplementation with targeted vitamins and minerals helps address these deficiencies and supports overall health. Furthermore, the increasing availability of specialized vitamin and mineral supplements formulated for celiac patients has expanded treatment options. Rising awareness of the importance of proper nutrition in celiac disease management further contributes to the segment's growth.

Gluten-free diets are projected to grow at a CAGR of 10.8% over the forecast period. Individuals with celiac disease require a strict gluten-free diet to manage their symptoms. However, there is a growing demand for gluten-free products worldwide because of the increasing prevalence of celiac disease and other food allergies. Celiac disease is an autoimmune disorder caused by gluten-containing food consumption, leading to gut inflammation and other health issues. Moreover, individuals are increasingly focused on health and wellness, leading to a shift in dietary preferences. Nowadays, restaurants, cafés, and home-cooked are involved in increased consumption of gluten-free products such as bread, cookies, and other bakery items, resulting in market growth.

Celiac Disease Treatment Market By Route of Administration Insights

The oral route of administration led the market and accounted for the largest revenue share of 62.7% in 2024. Orally consumable medicines have attained huge acceptance as an effective method to control celiac disease, address symptoms, and minimize inflammation in the digestive tract. The oral route of administration includes gluten-free items as well as any prescription medications or supplements because the core of the celiac disease path is adherence to a rigorous gluten-free diet. Furthermore, in severe conditions, oral immunosuppressants such as azathioprine (Imuran) may be directed to control the immunological response. In addition, pharmaceutical companies focus on R&D to enhance new oral medicines that improve the health of patients engaged with celiac disease. This boosts the growth of the market during the forecast period.

The parenteral route of administration is expected to grow at a CAGR of 10.4% over the forecast period. This growth is attributed to the increasing recognition of celiac disease has led to a higher patient population requiring effective treatment options. Parenteral administration allows for rapid delivery of medications, particularly in patients who may have difficulty absorbing nutrients orally due to intestinal damage. Furthermore, advancements in drug formulations and the development of new therapies targeting celiac disease symptoms enhance the appeal of parenteral routes, driving their adoption in clinical settings.

Celiac Disease Treatment Market By Distribution Channel Insights

The hospitals dominated the market and held the largest revenue share of 51.0% in 2024, owing to the rising aging population, increasing prevalence of celiac diseases, and the need for betterment in healthcare. Hospitals are significant & crucial in the diagnosis, treatment, and management of celiac disease. They serve as primary sites for diagnostic procedures which help in the diagnosing and confirmation of celiac disease. It offers specialist assistance on treatment alternatives, such as gluten-free diet implementation, nutritional therapy with suitable dietary plans, and monitoring for any circumstances.

Research centers are expected to grow at a CAGR of 9.6% over the forecast period. The growth factors include a prominent rise and focus on investments in research and development for the treatment of celiac diseases. Key market players and governments are spending on newer medications and enhancing the capabilities of treatments and various drug clinical trials to obtain better results.

Celiac Disease Treatment Market By Regional Insights

North America celiac disease treatment market dominated the global market and accounted for the largest revenue share of 41.8% in 2024. This growth is attributed to the rising prevalence of celiac diseases, rising awareness among citizens, the presence of major companies, and a strong supply channel of medications in the region. In addition, with the consumption of gluten-containing foods, the prevalence of the disease is growing in the region, resulting in advanced and timely diagnosis of celiac diseases with the requirement of improved treatment options.

U.S. Celiac Disease Treatment Market Trends

The celiac disease treatment market in the U.S. dominated the North American market with a revenue share of 88.4% in 2024 attributed to the consumption of alcoholic beverages, and fast food increasing in the region, which is a major risk factor for all age groups, giving rise to celiac disease. In addition, packaged food with gluten and irregular dietary patterns are due to hectic work life, and an increasing preference for ready-to-eat food results in increasing diseases. Therefore, the high consumption of gluten-containing food and the prevalence of celiac diseases result in the need for celiac disease treatment, fueling the market during the forecast period.

Europe Celiac Disease Treatment Market Trends

Europe celiac disease treatment market is expected to grow significantly. This growth is driven by the rising number of geriatrics, more active lifestyles in European countries, and technological developments in healthcare. Furthermore, advancements in diagnostic technologies and a growing gluten-free food industry support market expansion. Increased healthcare expenditures further facilitate the development of new treatment options and improved patient care.

The celiac disease treatment market in the UK is expected to witness substantial growth over the forecast period. This growth is attributed to the increasing prevalence of celiac disease and other food allergies by citizens, which has resulted in demand for gluten-free products. In addition, the UK market is experiencing continuous growth due to the requirement for diagnosis and treatment of celiac diseases to prevent complexity, thereby propelling the market growth.

Asia Pacific Celiac Disease TreatmentMarket Trends

The Asia Pacific celiac disease treatment market is anticipated to grow at a CAGR of 13.1% over the forecast period. This growth is attributed to the increasing awareness about the disease and the increasing elderly population in countries such as India, China, Japan, and South Korea. Furthermore, the expanding gluten-free food industry also contributes significantly, alongside growing healthcare expenditures that support better treatment options and patient care.

The China celiac disease treatment market growth is expected to be driven by the increased awareness of celiac disease and its timely treatment, rising healthcare expenditures, suitable and strong economic conditions, and technical enhancements that drive the market. The major factor that propels the growth of the celiac disease treatment market in the country is the awareness of celiac disease among the citizens and the increasing elderly population. As more people become aware of celiac disease, they are likely to prefer early diagnostics and treatment, which is leading to increased demand for celiac disease treatment.

Some of the prominent players in the celiac disease treatment market include:

• Teva Pharmaceutical Industries Ltd.
• Amgen Inc.
• Amneal Pharmaceuticals LLC. 
• Glenmark Life Sciences Limited
• Takeda Pharmaceutical Company Limited.
• Hikma Pharmaceuticals PLC
• Viatris Inc.
• Zydus Pharmaceuticals, Inc.
• Novartis AG
• BioLineRx Ltd.

Celiac Disease Treatment Market Recent Developments

• In February 2024, Novartis received the FDA approval of Xolair (omalizumab) as the first and only medication for reducing allergic reactions in individuals aged one and older with IgE-mediated food allergies. This approval followed the successful Phase III OUtMATCH study, demonstrating that Xolair significantly helps patients tolerate small amounts of allergens including peanuts and milk.

Segments Covered in the Report

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2034. For this study, Nova one advisor, Inc. has segmented the celiac disease treatment market

Treatment

• Vitamins & Minerals
• Gluten-free Diet
• Medical Therapies

• • Infliximab
  • Larazotide Acetate
  • Azathioprine
  • Budesonide
  • Others

By Route of Administration

• Oral
• Parenteral

By Distribution Channel

• Hospitals
• Research Centers
• Others

By Regional

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa (MEA)